Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 94.83 M88.73 M75.43 M96.87 M 355.86 M Research & development ———— — Operating income 64.92 M79.28 M92.05 M64.02 M 300.27 M Non-Operating Income, Total 3.35 M3.13 M2.73 M2.32 M 11.53 M Interest expense, net of interest capitalized 34.11 M33.85 M31.54 M32.5 M 132 M Non-Operating Income, excl. Interest Expenses -34.11 M-33.85 M-31.54 M-32.5 M -132 M Unusual income/expense 3.35 M3.13 M2.73 M2.32 M 11.53 M Pretax income 34.16 M48.57 M63.24 M33.19 M 179.16 M Equity in earnings ———— — Taxes 11.45 M15.95 M18.98 M6.71 M 53.1 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 22.71 M32.62 M44.25 M26.48 M 126.06 M Discontinued operations ———— — Net income 22.71 M32.62 M44.25 M26.48 M 126.06 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 22.71 M32.62 M44.25 M26.48 M 126.06 M Basic earnings per share (Basic EPS) 0.120.170.230.13 0.65 Diluted earnings per share (Diluted EPS) 0.120.170.230.14 0.66 Average basic shares outstanding 190.29 M190.43 M190.79 M193.41 M — Diluted shares outstanding 190.9 M191.21 M191.25 M194.03 M — EBITDA 105.5 M117.34 M130.44 M104.31 M 457.59 M EBIT 64.92 M79.28 M92.05 M64.02 M 300.27 M Cost of revenue 201.05 M207.28 M204.26 M202.78 M 815.36 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 40.58 M38.06 M38.39 M40.29 M 157.32 M